Journal ArticleDOI
Advances and challenges in targeting FGFR signalling in cancer
TLDR
The increasing understanding of the differences between diverse mechanisms of oncogenic activation of FGFR, and the factors that determine response and resistance to FGFR targeting are discussed.Abstract:
Fibroblast growth factors (FGFs) and their receptors (FGFRs) regulate numerous cellular processes. Deregulation of FGFR signalling is observed in a subset of many cancers, making activated FGFRs a highly promising potential therapeutic target supported by multiple preclinical studies. However, early-phase clinical trials have produced mixed results with FGFR-targeted cancer therapies, revealing substantial complexity to targeting aberrant FGFR signalling. In this Review, we discuss the increasing understanding of the differences between diverse mechanisms of oncogenic activation of FGFR, and the factors that determine response and resistance to FGFR targeting.read more
Citations
More filters
Journal Article
Patterns of Somatic Mutation in Human Cancer Genomes
TL;DR: In this paper, the coding exons of the family of 518 protein kinases were sequenced in 210 cancers of diverse histological types to explore the nature of the information that will be derived from cancer genome sequencing.
Journal ArticleDOI
Molecular therapies and precision medicine for hepatocellular carcinoma
TL;DR: Treatment advances have been made in the past few years, and further advancements are expected in the near future, including biomarker-driven treatments and immunotherapies, as discussed in this Review.
Journal ArticleDOI
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa,Ghassan K. Abou-Alfa,Vaibhav Sahai,Antoine Hollebecque,Gina M. Vaccaro,Davide Melisi,Raed Al-Rajabi,Andrew Scott Paulson,Mitesh J. Borad,David Gallinson,Adrian Murphy,Do Youn Oh,Efrat Dotan,Daniel V.T. Catenacci,Eric Van Cutsem,Tao Ji,Christine F. Lihou,Hui-Ling Zhen,Luis Féliz,Arndt Vogel +19 more
TL;DR: These data support the therapeutic potential of pemigatinib in previously treated patients with cholangiocarcinoma who have FGFR2 fusions or rearrangements.
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis : role of fibroblast growth factor receptor-2
Christine L. Chaffer,Janelle Brennan,Janelle Brennan,John Slavin,Tony Blick,Erik W. Thompson,Elizabeth D. Williams,Elizabeth D. Williams +7 more
TL;DR: In this paper, the importance of mesenchymal-to-epithelial transition (MET) in the formation of clinically significant metastasis was addressed, and it was found that the more metastatic sublines had acquired epithelial characteristics.
Journal ArticleDOI
PROTACs: great opportunities for academia and industry.
TL;DR: Although PRTOACs have been widely explored throughout the world and have outperformed not only in cancer diseases, but also in immune disorders, viral infections and neurodegenerative diseases, more efforts are needed to gain to get deeper insight into the efficacy and safety of PROTACs in the clinic.
References
More filters
Journal ArticleDOI
Meta-Analysis: A Constantly Evolving Research Integration Tool
TL;DR: The four articles in this special section onMeta-analysis illustrate some of the complexities entailed in meta-analysis methods and contributes both to advancing this methodology and to the increasing complexities that can befuddle researchers.
Journal ArticleDOI
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
Jianjiong Gao,Bulent Arman Aksoy,Ugur Dogrusoz,Gideon Dresdner,Benjamin Gross,S. Onur Sumer,Yichao Sun,Anders Jacobsen,Rileen Sinha,Erik Larsson,Ethan Cerami,Chris Sander,Nikolaus Schultz +12 more
TL;DR: A practical guide to the analysis and visualization features of the cBioPortal for Cancer Genomics, which makes complex cancer genomics profiles accessible to researchers and clinicians without requiring bioinformatics expertise, thus facilitating biological discoveries.
Journal Article
Patterns of Somatic Mutation in Human Cancer Genomes
TL;DR: In this paper, the coding exons of the family of 518 protein kinases were sequenced in 210 cancers of diverse histological types to explore the nature of the information that will be derived from cancer genome sequencing.
Journal ArticleDOI
Patterns of somatic mutation in human cancer genomes
Christopher Greenman,Philip J. Stephens,Raffaella Smith,Gillian L. Dalgliesh,Christopher I. Hunter,Graham R. Bignell,Helen Davies,Jon W. Teague,Adam Butler,Claire Stevens,Sarah Edkins,Sarah O’Meara,Imre Vastrik,Esther Schmidt,Tim Avis,Syd Barthorpe,Gurpreet Bhamra,Gemma Buck,Bhudipa Choudhury,Jody Clements,Jennifer Cole,Ed Dicks,Simon A. Forbes,Kris Gray,Kelly Halliday,Rachel Harrison,Katy Hills,Jon Hinton,Andy Jenkinson,David T. Jones,Andy Menzies,Tatiana Mironenko,Janet Perry,Keiran Raine,Dave Richardson,Rebecca Shepherd,Alexandra Small,Calli Tofts,Jennifer Varian,Tony Webb,Sofie West,Sara Widaa,Andrew D. Yates,Daniel P. Cahill,David N. Louis,Peter Goldstraw,Andrew G. Nicholson,Francis Brasseur,Leendert H. J. Looijenga,Barbara L. Weber,Yoke Eng Chiew,Anna deFazio,Mel Greaves,Anthony R. Green,Peter J. Campbell,Ewan Birney,Douglas F. Easton,Georgia Chenevix-Trench,Min-Han Tan,Sok Kean Khoo,Bin Tean Teh,Siu Tsan Yuen,Suet Yi Leung,Richard Wooster,P. Andrew Futreal,Michael R. Stratton,Michael R. Stratton +66 more
TL;DR: More than 1,000 somatic mutations found in 274 megabases of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers reveal the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.
Journal ArticleDOI
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes,David Beare,Prasad Gunasekaran,Kenric Leung,Nidhi Bindal,Harry Boutselakis,Minjie Ding,Sally Bamford,Charlotte G. Cole,Sari Ward,Chai Yin Kok,Mingming Jia,Tisham De,Jon W. Teague,Michael R. Stratton,Ultan McDermott,Peter J. Campbell +16 more
TL;DR: COSMIC, the Catalogue Of Somatic Mutations In Cancer is the world's largest and most comprehensive resource for exploring the impact of somatic mutations in human cancer, describing 2 002 811 coding point mutations in over one million tumor samples and across most human genes.
Related Papers (5)
Fibroblast growth factor signalling: from development to cancer
Nicholas C. Turner,Richard Grose +1 more
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu,Fengyun Su,Shanker Kalyana-Sundaram,Nickolay A. Khazanov,Bushra Ateeq,Xuhong Cao,Robert J. Lonigro,Pankaj Vats,Rui Wang,Su-Fang Lin,Ann Joy Cheng,Lakshmi P. Kunju,Javed Siddiqui,Scott A. Tomlins,Peter Wyngaard,Seth Sadis,Sameek Roychowdhury,Maha Hussain,Felix Y. Feng,Mark M. Zalupski,Moshe Talpaz,Kenneth J. Pienta,Daniel R. Rhodes,Dan R. Robinson,Arul M. Chinnaiyan +24 more